Use of Ticagrelor in Korean ACS Patients: The BRILIANT KOREA Registry

Clinical Trial ID NCT02521038

Rank	Title	Journal	Year	PubWeight™‹?›
1	Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans.	J Am Coll Cardiol	2013	2.35
2	Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial.	Circulation	2013	2.03
3	Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.	Circulation	2013	1.77
4	Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial.	J Am Coll Cardiol	2014	0.85
5	Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study.	Am Heart J	2013	0.81
6	Ticagrelor for acute coronary syndromes.	Expert Rev Cardiovasc Ther	2013	0.79
7	Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes.	Am J Cardiol	2013	0.78